Prot #INCB-MA-MF-401: Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date6/12/18 → 6/12/24

Funding

  • Syneos Health, Inc. ((OE) Prot #INCB-MA-MF-401 // (OE) Prot #INCB-MA-MF-401)
  • Incyte Corporation ((OE) Prot #INCB-MA-MF-401 // (OE) Prot #INCB-MA-MF-401)